8-K - Delek Logistics Partners, LP (0001552797) (Filer)
Live Feed
Delayed 3mBuys · SEC · FDA · Financials · Leadership Updates
Signed out · 3-min delay · Sign up for real-time
- Delek Logistics Partners L.P. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 20-F filed by Phoenix New Media Limited
20-F - Phoenix New Media Ltd (0001509646) (Filer)
- Agios Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - AGIOS PHARMACEUTICALS, INC. (0001439222) (Filer)
- Delek US Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Delek US Holdings, Inc. (0001694426) (Filer)
- SEC Form 6-K filed by ASE Technology Holding Co. Ltd.
6-K - ASE Technology Holding Co., Ltd. (0001122411) (Filer)
- Prosperity Bancshares Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - PROSPERITY BANCSHARES INC (0001068851) (Filer)
- SEC Form 6-K filed by Nova Minerals Limited
6-K - Nova Minerals Ltd (0001852551) (Filer)
- SEC Form NT 20-F filed by Micropolis AI Robotics
NT 20-F - Micropolis AI Robotics (0001993431) (Filer)
- Entergy reports first quarter 2026 financial results
Company affirms 2026 guidance, raises longer-term outlooksNEW ORLEANS, April 29, 2026 /PRNewswire/ -- Entergy Corporation (NYSE:ETR) reported first quarter 2026 earnings per share of 83 cents on an as-reported basis and 86 cents on an adjusted (non-GAAP) basis. "It's shaping up to be another exciting year," said Drew Marsh, Entergy Chair and Chief Executive Officer. "We announced another major hyperscale agreement in Louisiana that includes an additional estimated $2 billion of savings for retail customers consistent with our Fair Share Plus pledge. The fundamentals of our comp
- Cognizant Reports First Quarter 2026 Results
Revenue growth in upper half of guidance range; double digit adjusted EPS growth year-over-year;21% quarterly bookings growth, driven by seven large dealsRevenue of $5.4 billion increased 5.8% year-over-year or 3.9% in constant currency1Operating margin of 15.6% decreased 110 basis points year-over-year; Adjusted Operating Margin1 of 15.6% increased 10 basis points year-over-yearGAAP EPS of $1.39 increased 3.7% year-over-year; Adjusted EPS1 of $1.40 increased 13.8% year-over-yearTrailing 12-month bookings of $29.6 billion increased 11% year-over-year, driven by 21% growth in the first quarter; 7 large deals signed in the first quarter2026 constant currency revenue growth guidance is unchange
- CGI reports second quarter Fiscal 2026 results
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroomRevenue up 3.3% with diluted EPS accretion of 10.6%Q2-F2026 performance highlightsRevenue of $4.16 billion, up 3.3% year-over-year or 1.6% year-over-year in constant currency1;Earnings before income taxes of $617.7 million, up 6.0% year-over-year, for a margin1 of 14.9%;Adjusted earnings before interest and taxes1,2 of $691.6 million, up 3.9% year-over-year, for a margin1 of 16.6%;Net earnings of $444.7 million, up 3.5% year-over-year, for a margin1 of 10.7%, and diluted EPS of $2.09, up 10.6% year-over-year;Adjusted net earnings1,2 of $483.4 million, up 0.6% year-over-year, for a margin1 of 11.6%, and adjusted diluted EPS1,2 of $2.27,
- Central Pacific Financial Reports First Quarter 2026 Earnings of $20.7 Million
First Quarter Highlights: Net income of $20.7 million, or $0.78 per diluted share Return on average assets of 1.12% and return on average equity of 13.90% Net interest margin of 3.53% and efficiency ratio of 59.87% Total loans of $5.32 billion, increased by $31.3 million from the prior quarter Total deposits of $6.70 billion, increased by $89.6 million from the prior quarter Repurchased 321,396 shares of common stock at a total cost of $10.5 million during the quarter Other Highlights: CPF Board of Directors approved a second quarter cash dividend of $0.29 per share Central Pacific Bank was named the U.S. Small Business Administration (SBA) Lender of the Year in H
- Delek Logistics Reports First Quarter 2026 Results
Delek Logistics reported net income of $32.4 million or $0.60 per unit, and adjusted EBITDA of $132.3 million Successfully completed drilling of our first acid gas injection (AGI) well, progressing our sour gas processing, treating and handling solution at the Libby Gas Complex Signed new revolving credit facility, increasing borrowing capacity by $150 million and extending maturities to 2031 Strong first quarter execution allows us to reiterate 2026 EBITDA Guidance of $520 million to $560 million Increased economic separation from DK as we continue to increase EBITDA from third party sources Continued our consistent distribution growth with our 53rd consecutive quarterly i
- Delek US Holdings Reports First Quarter 2026 Results
Delek US reported a first quarter net loss of $201.3 million or $(3.34) per share, adjusted net income of $4.7 million or $0.08 per share and adjusted EBITDA of $211.7 million Excluding the impacts of the RVO adjustment, adjusted EPS was $(0.98) per share and adjusted EBITDA was $129.4 million Completed the Big Spring Refinery turnaround safely, within budget and on time Improves overall refining profitability through better margin capture and lower costs Advanced key objectives of Enterprise Optimization Plan ("EOP"), increasing the annual run-rate cash flow improvements to ~$220 million from ~$200 million Announced refinancing of the revolving credit facilities for bot
- TPG Mortgage Investment Trust, Inc. Reports First Quarter 2026 Results
TPG Mortgage Investment Trust, Inc. ("MITT," "we," the "Company," or "our") (NYSE:MITT) today reported financial results for the quarter ended March 31, 2026. MANAGEMENT REMARKS "Despite a challenging macroeconomic backdrop that pressured book values across the industry, our disciplined leverage profile, consistent capital rotation into higher-returning residential investments, and continued focus on scaling profitability at Arc Home produced EAD of $0.26 for the first quarter, more than covering our recently increased $0.24 dividend" said T.J. Durkin, Chief Executive Officer and President. "Notably, we have been able to raise our common dividend in four of the last six quarters and bel
- Parsons Reports First Quarter 2026 Results
Q1 2026 Financial Highlights Q1 revenue of $1.5 billion decreased 4% year-over-year and 8% on an organic basisRevenue growth of 8% excluding confidential contract; 3% on an organic basisNet income of $53 million decreased $13 million year-over-yearAdjusted EBITDA increased 1% to $151 million, a Q1 recordAdjusted EBITDA margin expanded 50 basis points to a record 10.1%Cash flow used in operating activities of $4 million, a Q1 recordBook-to-bill ratio of 1.4x in both segments extends company streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPOTotal and funded backlog increased to a record $9.3 billion and $6.6 billion, respectivelyReiterating fiscal year 2026 guid
- Quarterly Activities and Cashflow Report - March 2026
Operational Momentum at Estelle: Advancing Gold Exploration, Antimony Development, and US Redomiciliation Melbourne, Australia, April 29, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited ("Nova" and the "Company")(NASDAQ:NVA) (ASX: NVA), (FRA: QM3), a gold and critical minerals exploration and development stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, U.S.A. provides its quarterly activities and cashflow report for the quarter ended March 31, 2026. Highlights Strong results from the 2025 drilling program at RPM North and RPM Valley confirmed broad near-surface gold mineralisation and high-grade zones, supporting resource growth and advancement
- Agios Reports First Quarter 2026 Financial Results and Provides Business Update
Mitapivat (PYRUKYND® and AQVESME™) generated worldwide net revenues of $20.7 million in the first quarter of 2026, compared to $8.7 million in the first quarter of 2025Strong initial U.S. commercial launch of AQVESME in thalassemia, with 242 prescriptions written as of March 31, 2026Company plans to submit mitapivat sNDA for sickle cell disease in the second quarter of 2026Pipeline advancing to multiple value-driving inflection points in 2026, including two Phase 2 readouts for next-generation PK activator tebapivat$1.0 billion in cash, cash equivalents, and marketable securities as of March 31, 2026 CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:
- Ares Appoints Peter Ogilvie as Chief Operating Officer and Head of Strategy
Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that Peter Ogilvie has been appointed as Chief Operating Officer and Head of Strategy, where he will support the leadership team in executing the firm's strategic growth initiatives while scaling some of Ares' key global operating capabilities. Mr. Ogilvie currently serves as a Partner and Head of the Ares Corporate Strategy Group, where he has played a central role in shaping the firm's long‑term strategic direction. He joined Ares in 2007 on the direct lending team and has been instrumental in the acquisitions of Allied Capital, American Capital, Black Creek Group, Landmark